Defunct Company
Total Trials
9
As Lead Sponsor
As Collaborator
0
Total Enrollment
910
NCT00045136
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 31, 2002
Completion: Not specified
NCT00039754
A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma
Start: Mar 31, 2002
NCT00083564
Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma
Phase: Phase 3
Start: Mar 31, 2004
NCT00116610
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Phase: Phase 2
Start: Jun 30, 2005
Completion: Mar 31, 2008
NCT00478946
A Study of Picoplatin in Colorectal Cancer
Start: Apr 30, 2006
Completion: Jun 30, 2010
NCT00448734
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Start: Jun 30, 2006
Completion: Jul 31, 2010
NCT00465491
Study of Picoplatin Efficacy After Relapse
Start: Apr 30, 2007
NCT00465725
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
Phase: Phase 1
Completion: Jul 31, 2009
NCT00710697
Cardiac Safety Assessment Study of Picoplatin in Solid Tumors
Start: Jun 30, 2008